{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:43:30Z","timestamp":1792759410504,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.mcn.2026.104130","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:35:40Z","timestamp":1792132540000},"page":"104130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neuroinflammation in Alzheimer's disease: From glial cell states and molecular networks to biomarkers and precision therapeutics"],"prefix":"10.1016","volume":"139","author":[{"given":"Priyanka","family":"Samantaray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mcn.2026.104130_bb0005","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1038\/s41380-026-03505-7","article-title":"TREM2 in neurodegeneration and diseases","volume":"31","author":"Abdulkhaliq","year":"2026","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/13872877251411561","article-title":"The role of astrocytes in Alzheimer's disease: pathophysiology, biomarkers, and therapeutic potential","volume":"110","author":"Abedin","year":"2026","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.mcn.2026.104130_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2023.100065","article-title":"Cognitive resilience and severe Alzheimer's disease neuropathology","volume":"3","author":"Ahangari","year":"2023","journal-title":"Aging Brain"},{"issue":"11","key":"10.1016\/j.mcn.2026.104130_bb0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41423-022-00922-w","article-title":"How location and cellular signaling combine to activate the NLRP3 inflammasome","volume":"19","author":"Akbal","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"22","key":"10.1016\/j.mcn.2026.104130_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216288","article-title":"Blood-brain barrier breakdown in Alzheimer's disease: mechanisms and targeted strategies","volume":"24","author":"Alkhalifa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcn.2026.104130_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2018.00338","article-title":"Hyperphosphorylation of tau associates with changes in its function beyond microtubule stability","volume":"12","author":"Alonso","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines11020335","article-title":"The future of precision medicine in the cure of Alzheimer's disease","volume":"11","author":"Arafah","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.mcn.2026.104130_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108462","article-title":"Urine biomarkers for Alzheimer's disease: a new opportunity for wastewater-based epidemiology?","volume":"184","author":"Armenta-Castro","year":"2024","journal-title":"Environ. Int."},{"issue":"8","key":"10.1016\/j.mcn.2026.104130_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70404","article-title":"An integrated view of the relationships between amyloid, tau, and inflammatory pathophysiology in Alzheimer's disease","volume":"21","author":"Arnsten","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.mcn.2026.104130_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0055","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4103\/ni.ni_1073_22","article-title":"Role of nonsteroidal anti-inflammatory drugs as a protective factor in Alzheimer's disease: a systematic review and meta-analysis","volume":"72","author":"Asthana","year":"2024","journal-title":"Neurol. India"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-021-00939-9","article-title":"Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231","volume":"13","author":"Bayoumy","year":"2021","journal-title":"Alzheimer's Res. Ther."},{"issue":"7399","key":"10.1016\/j.mcn.2026.104130_bb7000","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","article-title":"Apolipoprotein E controls cerebrovascular integrity via cyclophilin A","volume":"485","author":"Bell","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mcn.2026.104130_bb0065","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mcn.2026.104130_bb0070","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41582-021-00549-x","article-title":"Peripheral and central immune system crosstalk in Alzheimer disease: a research prospectus","volume":"17","author":"Bettcher","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.mcn.2026.104130_bb0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological staging of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0080","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.tips.2025.04.007","article-title":"Targeting the NLRP3 inflammasome for inflammatory disease therapy","volume":"46","author":"Cabral","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"7999","key":"10.1016\/j.mcn.2026.104130_bb0085","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41586-023-06935-3","article-title":"A molecular switch for neuroprotective astrocyte reactivity","volume":"626","author":"Cameron","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0095","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer's disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0100","article-title":"Alzheimer's disease drug development pipeline: 2026","volume":"12","author":"Cummings","year":"2026","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.mcn.2026.104130_bb0110","article-title":"Mitochondrial dysfunction in Alzheimer's disease","volume":"107","author":"D'Alessandro","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.mcn.2026.104130_bb0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0120","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0125","doi-asserted-by":"crossref","first-page":"583","DOI":"10.15252\/embj.201694591","article-title":"Young microglia restore amyloid plaque clearance of aged microglia","volume":"36","author":"Daria","year":"2017","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.mcn.2026.104130_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/arclin\/acae019","article-title":"Plasma biomarkers for Alzheimer's and related dementias: a review and outlook for clinical neuropsychology","volume":"39","author":"Dark","year":"2024","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13024-024-00719-7","article-title":"The concept of resilience to Alzheimer's disease: current definitions and cellular and molecular mechanisms","volume":"19","author":"de Vries","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0140","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2026.104130_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1213968","article-title":"A how-to guide for a precision medicine approach to the diagnosis and treatment of Alzheimer's disease","volume":"15","author":"Devi","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.mcn.2026.104130_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer's disease: role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0155","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","article-title":"Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease","volume":"29","author":"Dhapola","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.mcn.2026.104130_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102471","article-title":"Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease","volume":"101","author":"Fan","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2026.104130_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105080","article-title":"A1\/A2 astrocytes in central nervous system injuries and diseases: angels or devils?","volume":"148","author":"Fan","year":"2021","journal-title":"Neurochem. Int."},{"issue":"19","key":"10.1016\/j.mcn.2026.104130_bb0170","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.cell.2025.08.023","article-title":"Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling","volume":"188","author":"Faust","year":"2025","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mcn.2026.104130_bb0175","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/cells12081207","article-title":"The functions and phenotypes of microglia in Alzheimer's disease","volume":"12","author":"Fujikawa","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.mcn.2026.104130_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4761054","article-title":"Biomarkers for Alzheimer's disease in saliva: a systematic review","volume":"2019","author":"Gleerup","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.mcn.2026.104130_bb0190","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/ITT.S305420","article-title":"The role of complement in synaptic pruning and neurodegeneration","volume":"10","author":"Gomez-Arboledas","year":"2021","journal-title":"Immunotargets Ther."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0195","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/ejn.15613","article-title":"Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: an update","volume":"55","author":"Gouilly","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"10.1016\/j.mcn.2026.104130_bb0200","doi-asserted-by":"crossref","first-page":"e797","DOI":"10.1016\/S2666-7568(22)00219-7","article-title":"Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease","volume":"3","author":"Gregory","year":"2022","journal-title":"Lancet Healthy Longev."},{"issue":"12","key":"10.1016\/j.mcn.2026.104130_bb0205","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation","volume":"22","author":"Grubman","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0210","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bpa.12763","article-title":"Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer's disease brains","volume":"30","author":"Gui","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.mcn.2026.104130_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73673-1","article-title":"PET amyloid in normal aging: direct comparison of visual and automatic processing methods","volume":"10","author":"Haller","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0220","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer's disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J. Cell Biol."},{"issue":"10","key":"10.1016\/j.mcn.2026.104130_bb0225","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-024-01104-7","article-title":"Neuroinflammation in Alzheimer disease","volume":"25","author":"Heneka","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.mcn.2026.104130_bb0235","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209537","article-title":"Blood astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis","volume":"103","author":"Holper","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2026.104130_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2025.103765","article-title":"A practical overview of the use of amyloid-PET Centiloid values in clinical trials and research","volume":"46","author":"Iaccarino","year":"2025","journal-title":"Neuroimage Clin."},{"issue":"8","key":"10.1016\/j.mcn.2026.104130_bb0245","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","volume":"20","author":"Jack","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.mcn.2026.104130_bb0255","article-title":"A systematic review and meta-analysis of basal microbiota and cognitive function in Alzheimer's disease: a potential target for treatment or a contributor to disease progression?","volume":"16","author":"Jimenez-Garc\u00eda","year":"2024","journal-title":"Alzheimers Dement. (Amst)"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0260","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/10717544.2018.1428243","article-title":"Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease","volume":"25","author":"Karthivashan","year":"2018","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.mcn.2026.104130_bb0265","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1093\/brain\/awad159","article-title":"The amyloid cascade hypothesis: an updated critical review","volume":"146","author":"Kepp","year":"2023","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.mcn.2026.104130_bb0275","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer's disease: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.mcn.2026.104130_bb0280","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/biom13030453","article-title":"The amyloid cascade hypothesis in Alzheimer's disease: should we change our thinking?","volume":"13","author":"Kurkinen","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.mcn.2026.104130_bb0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb8000","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3233\/JAD-160722","article-title":"Cerebrospinal fluid A\u03b242\/40 corresponds better than A\u03b242 to amyloid PET in Alzheimer's disease","volume":"55","author":"Lewczuk","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-230799","article-title":"The associations of phosphorylated tau 181 and tau 231 levels in plasma and cerebrospinal fluid with cognitive function in Alzheimer's disease: a systematic review and meta-analysis","volume":"98","author":"Li","year":"2024","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.mcn.2026.104130_bb0290","article-title":"NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer's disease","volume":"36","author":"Lian","year":"2016","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","article-title":"Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease","volume":"16","author":"Long","year":"2024","journal-title":"Alzheimer's Res. Ther."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0315","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2126272","article-title":"Periodontitis-related salivary microbiota aggravates Alzheimer's disease via gut-brain axis crosstalk","volume":"14","author":"Lu","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.mcn.2026.104130_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105273","article-title":"Tau associated peripheral and central neurodegeneration: identification of an early imaging marker for tauopathy","volume":"151","author":"Marquez","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.mcn.2026.104130_bb5000","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-immunol-101921-035222","article-title":"Immune activation in Alzheimer disease","volume":"42","author":"Mary","year":"2024","journal-title":"Annu. Rev. Immunol."},{"issue":"7761","key":"10.1016\/j.mcn.2026.104130_bb0325","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer's disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.mcn.2026.104130_bb0330","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4103\/1673-5374.390978","article-title":"Rebuilding insight into the pathophysiology of Alzheimer's disease through new blood-brain barrier models","volume":"19","author":"Matsuo","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.mcn.2026.104130_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.109941","article-title":"NLRP3 inflammasome signalling in Alzheimer's disease","volume":"252","author":"McManus","year":"2024","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0340","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","article-title":"Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease","volume":"11","author":"McQuade","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0345","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2174\/1567205020666230821141745","article-title":"Towards the integrative theory of Alzheimer's disease: linking molecular mechanisms of neurotoxicity, beta-amyloid biomarkers, and the diagnosis","volume":"20","author":"Molkov","year":"2023","journal-title":"Curr. Alzheimer Res."},{"issue":"8","key":"10.1016\/j.mcn.2026.104130_bb0350","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0046-8177(95)90001-2","article-title":"Glial cytokines in Alzheimer's disease: review and pathogenic implications","volume":"26","author":"Mrak","year":"1995","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0355","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41591-026-04273-1","article-title":"The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial","volume":"32","author":"Mummery","year":"2026","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.mcn.2026.104130_bb0360","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200235R","article-title":"Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration","volume":"36","author":"Murakami","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2026.104130_bb0365","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2023.11.031","article-title":"MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease","volume":"116","author":"Naeem","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0370","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3390\/ijms25021168","article-title":"Salivary biomarkers for Alzheimer's disease: a systematic review with meta-analysis","volume":"25","author":"Nijakowski","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0375","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/s41467-020-19737-2","article-title":"Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease","volume":"11","author":"Olah","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.mcn.2026.104130_bb0380","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.mcn.2026.104130_bb0385","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.2024.13855","article-title":"Blood biomarkers to detect Alzheimer disease in primary care and secondary care","volume":"332","author":"Palmqvist","year":"2024","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.mcn.2026.104130_bb0390","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer's disease: role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Perez Ortiz","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mcn.2026.104130_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110020","article-title":"Microglia and TREM2","volume":"257","author":"Pocock","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2026.104130_bb0400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-025-00815-2","article-title":"The neuroimmune nexus: unraveling the role of the mtDNA-cGAS-STING signal pathway in Alzheimer's disease","volume":"20","author":"Quan","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0405","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s12276-023-01146-2","article-title":"Current understanding of the Alzheimer's disease-associated microbiome and therapeutic strategies","volume":"56","author":"Seo","year":"2024","journal-title":"Exp. Mol. Med."},{"issue":"12","key":"10.1016\/j.mcn.2026.104130_bb0410","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-\u03b2(1\u201340) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcn.2026.104130_bb0415","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/bs.acc.2022.09.006","article-title":"Fluid biomarkers in Alzheimer's disease","volume":"112","author":"Simr\u00e9n","year":"2023","journal-title":"Adv. Clin. Chem."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0420","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb6000","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1172\/JCI81108","article-title":"Endothelial LRP1 transports amyloid-\u03b21\u201342 across the blood-brain barrier","volume":"126","author":"Storck","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0425","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.14336\/AD.2022.0130-1","article-title":"Discerning the role of blood brain barrier dysfunction in Alzheimer's disease","volume":"13","author":"Tao","year":"2022","journal-title":"Aging Dis."},{"issue":"5","key":"10.1016\/j.mcn.2026.104130_bb0430","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41582-025-01073-y","article-title":"Knowing the enemy: strategic targeting of complement to treat Alzheimer disease","volume":"21","author":"Tenner","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.mcn.2026.104130_bb0435","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","article-title":"Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.mcn.2026.104130_bb0440","article-title":"Neurofilament light (NfL) chain levels predict clinical decline in Alzheimer's disease: a systematic review and meta-analysis","volume":"9","author":"Thomas","year":"2025","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.mcn.2026.104130_bb0450","series-title":"FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval","author":"U.S. Food and Drug Administration","year":"2023"},{"key":"10.1016\/j.mcn.2026.104130_bb0455","series-title":"FDA Approves Treatment for Adults With Alzheimer's Disease","author":"U.S. Food and Drug Administration","year":"2024"},{"key":"10.1016\/j.mcn.2026.104130_bb0460","series-title":"FDA Clears First Blood Test Used in Diagnosing Alzheimer's Disease","author":"U.S. Food and Drug Administration","year":"2025"},{"issue":"4","key":"10.1016\/j.mcn.2026.104130_bb0465","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acschemneuro.5b00313","article-title":"TREM2 function in Alzheimer's disease and neurodegeneration","volume":"7","author":"Ulrich","year":"2016","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.mcn.2026.104130_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70905","article-title":"Long-term safety and efficacy of lecanemab in early Alzheimer's disease: results from the Clarity AD open-label extension study","volume":"21","author":"van Dyck","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0470","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0480","first-page":"484","article-title":"Impact of TSPO receptor polymorphism on [18F]GE-180 binding in healthy brain and pseudo-reference regions of neurooncological and neurodegenerative disorders","volume":"11","author":"Vettermann","year":"2021","journal-title":"Life (Basel)"},{"issue":"28","key":"10.1016\/j.mcn.2026.104130_bb0485","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.2174\/0929867329666220329204054","article-title":"Essential principles and recent progress in the development of TSPO PET ligands for neuroinflammation imaging","volume":"29","author":"Viviano","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0490","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnen\/nlac115","article-title":"Cognitive resistance to and resilience against multiple comorbid neurodegenerative pathologies and the impact of APOE status","volume":"82","author":"Walker","year":"2023","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0500","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40035-026-00571-3","article-title":"Neuroinflammation in Alzheimer's and Parkinson's diseases: pathogenic mechanisms and therapeutic strategies","volume":"15","author":"Wang","year":"2026","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.mcn.2026.104130_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1484373","article-title":"Mitochondrial dysfunction in Alzheimer's disease: a key frontier for future targeted therapies","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mcn.2026.104130_bb0505","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-150759","article-title":"Matrix metalloproteinase in blood-brain barrier breakdown in dementia","volume":"49","author":"Weekman","year":"2016","journal-title":"J. Alzheimer's Dis"},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0510","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tins.2023.11.010","article-title":"Complement-mediated synapse loss in Alzheimer's disease: mechanisms and involvement of risk factors","volume":"47","author":"Wen","year":"2024","journal-title":"Trends Neurosci."},{"issue":"6","key":"10.1016\/j.mcn.2026.104130_bb0515","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","article-title":"Tau PTM profiles identify patient heterogeneity and stages of Alzheimer's disease","volume":"183","author":"Wesseling","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.mcn.2026.104130_bb0520","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70504","article-title":"Amyloid PET and clinical management in a diverse, cognitively impaired population: the New IDEAS Study","volume":"21","author":"Windon","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.mcn.2026.104130_bb0525","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12031-022-02047-1","article-title":"Role of chemokines in the development and progression of Alzheimer's disease","volume":"72","author":"Wojcieszak","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.mcn.2026.104130_bb0530","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3233\/JAD-230199","article-title":"Microglia-astrocyte communication in Alzheimer's disease","volume":"95","author":"Wu","year":"2023","journal-title":"J. Alzheimer's Dis"},{"issue":"4","key":"10.1016\/j.mcn.2026.104130_bb0540","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/ejn.16085","article-title":"The performance of plasma phosphorylated tau231 in detecting Alzheimer's disease: a systematic review with meta-analysis","volume":"58","author":"Xu","year":"2023","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0545","doi-asserted-by":"crossref","first-page":"459","DOI":"10.14336\/AD.2023.0718","article-title":"The role of glial cells in synaptic dysfunction: insights into Alzheimer's disease mechanisms","volume":"15","author":"Yu","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.mcn.2026.104130_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2024.103917","article-title":"TREM2 in Alzheimer's disease: structure, function, therapeutic prospects, and activation challenges","volume":"128","author":"Zgorzynska","year":"2024","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.mcn.2026.104130_bb0570","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13024-025-00812-5","article-title":"Peripheral and central neuroimmune mechanisms in Alzheimer's disease pathogenesis","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"10","key":"10.1016\/j.mcn.2026.104130_bb0560","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/brainsci13101364","article-title":"Peripheral blood and cerebrospinal fluid levels of YKL-40 in Alzheimer's disease: a systematic review and meta-analysis","volume":"13","author":"Zhang","year":"2023","journal-title":"Brain Sci."},{"issue":"21","key":"10.1016\/j.mcn.2026.104130_bb0575","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.3390\/nu15214631","article-title":"Understanding the gut-brain axis and its therapeutic implications for neurodegenerative disorders","volume":"15","author":"Zheng","year":"2023","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.mcn.2026.104130_bb0580","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.3390\/jcm12103589","article-title":"Association between cerebrospinal fluid soluble TREM2, Alzheimer's disease and other neurodegenerative diseases","volume":"12","author":"Zhou","year":"2023","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.mcn.2026.104130_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2025.100446","article-title":"Donanemab in early symptomatic Alzheimer's disease: results from the TRAILBLAZER-ALZ 2 long-term extension","volume":"13","author":"Zimmer","year":"2026","journal-title":"J. Prev. Alzheimers Dis."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743126000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:01:19Z","timestamp":1792756879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743126000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":112,"alternative-id":["S1044743126000606"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104130","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation in Alzheimer's disease: From glial cell states and molecular networks to biomarkers and precision therapeutics","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2026.104130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104130"}}